MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study

Background: Indices for predicting survival are essential for assessing prognosis and assigning priority for liver transplantation in patients with liver cirrhosis. The model for end stage liver disease (MELD) has been proposed as a tool to predict mortality risk in cirrhotic patients. However, this model has not been validated beyond its original setting. Aim: To evaluate the short and medium term survival prognosis of a European series of cirrhotic patients by means of MELD compared with the Child-Pugh score. We also assessed correlations between the MELD scoring system and the degree of impairment of liver function, as evaluated by the monoethylglycinexylidide (MEGX) test. Patients and methods: We retrospectively evaluated survival of a cohort of 129 cirrhotic patients with a follow up period of at least one year. The Child-Pugh score was calculated and the MELD score was computed according to the original formula for each patient. All patients had undergone a MEGX test. Multivariate analysis was performed on all variables to identify the parameters independently associated with one year and six month survival. MELD values were correlated with both Child-Pugh scores and MEGX test results. Results: Thirty one patients died within the first year of follow up. Child-Pugh and MELD scores, and MEGX serum levels were significantly different among patients who survived and those who died. Serum creatinine, international normalised ratio, and MEGX60 were independently associated with six month mortality while the same variables and the presence of ascites were associated with one year mortality. MELD scores showed significant correlations with both MEGX values and Child-Pugh scores. Conclusions: In a European series of cirrhotic patients the MELD score is an excellent predictor of both short and medium term survival, and performs at least as well as the Child-Pugh score. An increase in MELD score is associated with a decrease in residual liver function.

[1]  R. Jalan,et al.  quantitative tests of liver function , 1995 .

[2]  G. Everson,et al.  Quantitative liver function tests define the functional severity of liver disease in early-stage cirrhosis. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  G. Aimo,et al.  Monoethylglicinexylidide test: A prognostic indicator of survival in cirrhosis , 1994, Hepatology.

[4]  R. Fisher,et al.  Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation. , 1993, Transplantation.

[5]  Emmet B. Keeffe,et al.  Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases , 1997 .

[6]  E. Keeffe.  Summary of guidelines on organ allocation and patient listing for liver transplantation. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  Nina Singh,et al.  Outcome of patients with cirrhosis requiring intensive care unit support: Prospective assessment of predictors of mortality , 1998, Journal of Gastroenterology.

[8]  R. Testa,et al.  Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis. , 1998, Hepato-gastroenterology.

[9]  H. Lautz,et al.  Assessment of pretransplant prognosis in patients with cirrhosis. , 1991, Transplantation.

[10]  M. Ziol,et al.  Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. , 2001, Journal of hepatology.

[11]  R. Jalan,et al.  Review article: quantitative tests of liver function. , 1995, Alimentary pharmacology & therapeutics.

[12]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[13]  A. Sanyal,et al.  Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis , 1994, Hepatology.

[14]  G. Ercolani,et al.  The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. , 2000, Surgery.

[15]  Rolf Fimmers,et al.  Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting , 2003, American Journal of Gastroenterology.

[16]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[17]  L. Forman,et al.  Predicting the prognosis of chronic liver disease: An evolution from child to MELD , 2001, Hepatology.

[18]  R. Bataller,et al.  A prognostic model for predicting survival in cirrhosis with ascites. , 2001, Journal of hepatology.

[19]  U. Meyer,et al.  Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4 , 1989, Clinical pharmacology and therapeutics.

[20]  B. Gulbis,et al.  Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score. , 1997, Journal of hepatology.

[21]  R. Testa,et al.  Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease. , 1997, The American journal of gastroenterology.

[22]  R. Wiesner,et al.  Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. , 1998, Transplantation.

[23]  R. Freeman,et al.  Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  To MELD or Not To MELD? , 2001, Hepatology.

[25]  M. Ryska,et al.  Evaluation of the selection process of liver transplant candidates with alcoholic liver cirrhosis in Ikem, Prague , 2001 .

[26]  American Association for the Study of Liver Diseases Postgraduate courses and 48th annual meeting. Chicago, Illinois, November 7-11, 1997. Abstracts. , 1997, Hepatology.

[27]  A. Sanyal,et al.  Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease. , 1996, Therapeutic drug monitoring.

[28]  H. Lautz,et al.  Predictors of one‐year pretransplant survival in patients with cirrhosis , 1991, Hepatology.

[29]  L. Grande,et al.  Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors. , 1998, Journal of hepatology.

[30]  S. Afford,et al.  Gene therapy for hepatocellular carcinoma—teaching old dogs new tricks , 2001, Hepatology.

[31]  A. Lu,et al.  Liver transplant candidate stratification systems. Implications for third-party payors and organ allocation. , 1994, Transplantation.

[32]  J. Coste,et al.  Costs and outcomes of liver transplantation in adults: a prospective, 1-year, follow-up study. GRETHECO study group. , 1999, Transplantation.

[33]  R. Carithers.  Liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[34]  H. Popper.  American Association for the Study of Liver Diseases: Symposium on Toxic Hepatic Injury , 1960 .

[35]  C. Wittekind,et al.  Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Function , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[36]  C. Zauner,et al.  Short‐term prognosis in critically ill patients with liver cirrhosis: an evaluation of a new scoring system , 2000, European journal of gastroenterology & hepatology.

[37]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[38]  Cobelli,et al.  The monoethylglycinexylidide test for grading of liver cirrhosis , 1999, Alimentary pharmacology & therapeutics.

[39]  Eric B. Edwards,et al.  MELD and PELD: Application of survival models to liver allocation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.